使MRIIDH

Nghi C D Truong1, Chandan Ganesh Bangalore Yogananda1, Benjamin C Wagner1

  • 1From the Departments of Radiology (N.C.D.T., C.G.B.Y., B.C.W., J.M.H., D.R., N.S., B.F., M.C.P., A.J.M., J.A.M.), Pathology (K.J.H.), and Neurologic Surgery (T.R.P.), The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390; Department of Bioengineering, The University of Texas at Dallas, Richardson, Tex (B.F.); Departments of Radiology (M.D.L., R.J.) and Neurosurgery (R.J.), New York University Grossman School of Medicine, New York, NY; and Department of Radiology, University of Wisconsin-Madison, Madison, Wis (R.J.B.).

概括

这项研究开发了一个MRI放射学框架,以预测在手术前在质瘤患者中异酸脱酶 (IDH) 突变状态. 该框架准确地确定了IDH突变状态,有助于结质瘤的预后.